Beijing Succeeder Technology

Beijing Succeeder Technology EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Beijing Succeeder Technology (688338.SS) as of Oct 27, 2026 is 66.56. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was 34.98 — a change of 90.27% (higher).

EV/FCF

66.56

YoY

90.27%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Beijing Succeeder Technology is 2025 66.56 . EV/FCF (Enterprise Value to Free Cash Flow) of Beijing Succeeder Technology was 2024 34.98 . It decreases by 90.27% higher compared to the previous year.

The Beijing Succeeder Technology EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
53.11 CNY
Jan 1, 2019
48.71 CNY
Jan 1, 2020
44.53 CNY
Jan 1, 2021
18.81 CNY
Jan 1, 2022
524.67 CNY
Jan 1, 2023
-166.52 CNY
Jan 1, 2024
34.98 CNY
Jan 1, 2025
66.56 CNY
The Beijing Succeeder Technology EV/FCF history
YEAREV/FCFYoY
66.56+90.27%
34.98-121.01%
-166.52-131.74%
524.67+2,688.65%
18.81-57.75%
44.53-8.58%
48.71-8.29%
53.11-45.47%
97.40+1.63%
95.83—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Succeeder Technology Stock analysis

What does Beijing Succeeder Technology do? Beijing Succeeder Technology Inc generates revenue through the research, development, production, and sales of detection instruments, reagents, and consumables for thrombosis and hemostasis in the in-vitro diagnosis field. The company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, and platelet aggregation, along with supporting reagents and consumables. Its product portfolio includes automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups, and SAW blood rheology special cleaning. The firm serves domestic and overseas markets with these offerings. The company's primary customers are medical institutions that require automated detection systems for blood-related diagnostics. Products like automatic coagulation testers and coagulation quality control kits are sold to these institutions for use in clinical settings. Reagents and consumables such as Newtonian fluid quality controls and reaction cups form recurring revenue streams through regular purchases. SAW blood rheology special cleaning is also part of the consumable product line sold to the same customer segment. Beijing Succeeder Technology Inc focuses on the in-vitro diagnosis sector, specifically targeting thrombosis and hemostasis detection. The firm's products are designed to meet the needs of medical institutions for accurate and efficient blood-related diagnostic testing. By offering a comprehensive range of instruments, reagents, and consumables, the company ensures ongoing customer engagement and repeat business through essential daily supplies. Beijing Succeeder Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Succeeder Technology stock

EV/FCF (Enterprise Value to Free Cash Flow) of Beijing Succeeder Technology is 66.56 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Beijing Succeeder Technology changed from 34.98 to 66.56, representing a 90.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Beijing Succeeder Technology since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Beijing Succeeder Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Beijing Succeeder Technology

All Key Metrics — Beijing Succeeder Technology